Articles tagged "Outcome"

2020 American Transplant Congress
Performance Evaluation of the Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) in Liver Transplant Candidates
P. Gomez, K. Zucker, J. Foote, C. Thomas, R. Anderson, R. Nathan, S. Mehta, N. Patel, M. Fallon, A. Seetharam
University of Arizona College of Medicine Phoenix, Phoenix, AZ
*Purpose: The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) tool is employed in candidate evaluation. SIPAT scoring and association with outcomes post liver transplant (LT)…
2020 American Transplant Congress
Identifying Factors Associated with Delayed Graft Function Severity Using the OPTN Database
K. Checchi¹, D. Stewart², A. Toll², J. Case¹, S. Kurian¹, C. Marsh¹
¹Scripps Health, La Jolla, CA, ²United Network for Organ Sharing Research Department, Richmond, VA
*Purpose: Delayed graft function (DGF) is a costly adverse outcome in kidney transplantation with negative implications for both graft and patient survival. Identifying factors associated…
2020 American Transplant Congress
Characteristics and Outcomes of Acetaminophen Overdose Related Hospitalizations Requiring Liver Transplant
A. Khan¹, N. Saleem², M. Bilal³, R. Tariq⁴, S. Singh⁵
¹West Virginia University-Charleston division, Charleston, WV, ²University of Tennessee Health Science Center, Memphis, TN, ³Beth Israel Deaconess Medical Center, Boston, MA, ⁴Rochester General Hospital, Rochester, NY, ⁵Charleston Area Medical Center, Charleston, WV
*Purpose: Acetaminophen overdose (AO) may lead to severe liver damage requiring an urgent liver transplant (LT). The data on hospital-related outcomes in patients with AO…
2020 American Transplant Congress
The Effect of UNOS Donor Policy Change on Distance from Recipient Hospital and the Effects on Mortality in Heart Transplantation
P. Kingsford¹, J. P. Li¹, C. J. Lum², A. D. Salimbangon³, G. S. Liu⁴, R. R. Chand⁵, P. Banankhah¹, P. A. Genyk¹, D. Vucicevic¹, K. Pandya¹, J. Rahman¹, M. Fong¹, L. Grazette¹, A. Kiankhooy¹, J. Nattiv¹, S. Hashmi¹, S. B. Nuno¹, J. Pizula¹, D. J. Miklin¹, A. E. Lee¹, K. Yang¹, S. Shah¹, A. S. Vaidya¹, A. M. Wolfson⁶, E. C. DePasquale¹
¹LAC-USC, Los Angeles, CA, ²The Queens Medical Center, Honolulu, HI, ³UCLA Medical Center, Los Angeles, CA, ⁴USC, Los Angeles, CA, ⁵Harbor-UCLA Medical Center, Los Angeles, CA, ⁶University of Arizona Sarver Heart Center, Tucson, AZ
*Purpose: In light of the recent change in the UNOS allocation policy, we sought to evaluate the impact of distance from recipient hospital on mortality.*Methods:…
2020 American Transplant Congress
The Clinical Relevance of cPRA in 0-ABDRDQ Mismatched Kidney Transplants
J. H. Lan¹, D. Chang¹, M. Kadatz¹, J. Gill¹, H. M. Gebel², J. S. Gill¹
¹Medicine, Division of Nephrology, University of British Columbia, Vancouver, BC, Canada, ²Pathology, Emory University, Atlanta, GA
*Purpose: The clinical relevance of immune sensitization as measured by cPRA in kidney transplantation remains uncertain.*Methods: We identified 4,057 adult, first, kidney only transplant recipients…
2020 American Transplant Congress
Utility of Estimated Glomerular Filtration Rate in Living Kidney Donor Candidates
Y. Lu¹, A. Naik¹, K. Woodside², R. Sung², R. Doshi³, R. Parasuraman¹, S. Norman¹, M. Doshi¹
¹Internal Medicine, University of Michigan, Ann Arbor, MI, ²Surgery, University of Michigan, Ann Arbor, MI, ³Vanderbilt University, Nashville, TN
*Purpose: Pre-donation renal function is an important determinant of future development of kidney disease in live kidney donors (LKD). In 2017, the Kidney Disease Improving…
2020 American Transplant Congress
Clinical Correlations Associated with Development of De Novo Donor-Specific Antibody in the First Year Following Kidney Transplant at a Single Center
J. M. Zimmerer¹, M. Basinger¹, B. A. Ringwald¹, R. Pelletier², A. Rajab¹, A. El-Hinnawi¹, M. Abdel-Rasoul¹, K. Washburn¹, G. L. Bumgardner¹
¹Ohio State University, Columbus, OH, ²Robert Wood Johnson Barnabas Health, New Brunswick, NJ
*Purpose: The development of de novo donor-specific antibody (dnDSA) portends inferior long-term graft survival. This study investigates the short-term clinical correlations associated with dnDSA that…
2020 American Transplant Congress
Validation of PROMIS Computer Adaptive Testing (CAT) Sleep Disturbance Item Bank in Kidney Transplant Recipients
J. Hussain¹, G. Chawla¹, N. Ullah¹, H. Rafiqzad¹, S. J. Bartlett², M. Li³, D. Howell⁴, J. D. Peipert⁵, M. Novak⁶, I. Mucsi¹
¹Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada, ²Centre for Health Outcomes Research, McGill University, Montreal, QC, Canada, ³Department of Supportive Care, Princess Margaret Hospital, Toronto, ON, Canada, ⁴Princess Margaret Cancer Centre, Faculty of Nursing, University of Toronto, Toronto, ON, Canada, ⁵Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, ⁶Centre for Mental Health, University Health Network, Toronto, ON, Canada
*Purpose: To assess the reliability and validity of the PROMIS Sleep Disturbance Item Bank using the Insomnia Severity Index as the primary legacy instrument in…
2020 American Transplant Congress
Kidney Transplant Outcomes in Incarcerated End Stage Renal Disease Patients
R. Rattanavich, T. Hoang, R. Villicana
Transplant institute, Loma Linda University, San Bernadino, CA
*Purpose: Kidney transplantation remains the treatment of choice for end stage renal disease as it improves mortality and morbidity. Outcomes of incarcerated ESRD patients who…
2020 American Transplant Congress
A Stroke Volume-Based Fluid Resuscitation Protocol Decreases Vasopressor Support and Increases Organ Yield in Brain-Dead Donors
G. F. Marklin
Mid-America Transplant, St Louis, MO
*Purpose: Brain-dead donors are frequently hypovolemic and hypotensive requiring vasopressor support. The goal of fluid resuscitation is to increase perfusion and oxygen delivery and avoid…